Dow Watch: Lucky Seven

The Dow Jones Industrial Average overcame midday selling pressure to keep its winning streak intact, extending it to seven straight days for the first time since April 2007.
Publish date:

(At 4:03 p.m. EDT)

Well, after all that, the


keeps its winning streak intact, finishing once again not far from the highs of the session. It took a round-about path to get there, though.

The Dow Jones Industrial Average jumped out to a strong start on the back of earnings from five different components, rising as many as 78 points. However, the blue-chip average took a short detour into negative territory, losing as many as 37 points before ultimately finishing up 67.79 points at 8915.94.

The Dow's seven-day winning streak, the first of this duration since one that ended April 20, 2007, has been good for about 770 points, or a whopping 9.5%. The Dow continues to inch closer to its highest levels of the year, set in January. Despite the recent move higher, some market observers continue to note that the market remains in a trading range.


(CAT) - Get Report



(MRK) - Get Report

were the best performers on the Dow, up 7.7% and 6.1%, respectively, following earnings releases this morning from both.

On the other hand,

United Technologies



(DD) - Get Report



(KO) - Get Report

were among the Dow's 13 laggards following their own earnings reports Tuesday.


(AA) - Get Report

, though, was the biggest decliner, losing 4.3% on no particular news at all.

Looking ahead, the Dow will get its direction Wednesday from


(BA) - Get Report



(PFE) - Get Report

, the latest two components to report quarterly results.


is expected to report a second-quarter profit of $1.21 a share on revenue of $17.15 billion, according to a Thomson Reuters poll of analysts. Pfizer, meanwhile, is expected to record a second-quarter profit of 47 cents a share on sales of $11.27 billion.